Abundnz has developed pAMS, a novel ultra sensitive assay for bioanalytical studies with large molecule drugs. The assay can be applied in pre-clinical and clinical studies, ranging from dose regimen studies to ADME and biodistribution studies.
pAMS Characteristics
- Highly sensitive and specific method
- High throughput
- Generic method: short development time
Benefits of pAMS technology
- Less drug compound required for testing
- Enables working with limited sample volumes
- Measurement of highly potent compounds
- Measurement of compounds with low bioavailability and short half-life
Applications of pAMS technology
- Protein drugs ranging from small synthetic peptides to large conjugated antibody molecules
- Biosimilars
- Biobetters
- Antibody-drug conjugates
- Nanoscale drugs and delivery systems
- Gene and cell therapy
- Cytotoxic drugs